DongKoo Bio & Pharma Co., Ltd.

KOSDAQ:A006620 株式レポート

時価総額：₩136.8b

DongKoo Bio & Pharma マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Cho Yong-Jun

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権30.6%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

更新なし

Recent updates

More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Aug 23
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

Jul 25
Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Mar 27
We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

CEO（最高経営責任者

Cho Yong-Jun

no data

在職期間

Mr. Cho Yong-Jun serves as the President at DongKoo Bio & Pharma Co., Ltd. and serves as its Chief Executive Officer.